Glucagon‑like  	Glucagon‑like  	 NNP	B-NP
peptide‑1  	peptide‑1  	 NNP	O
protects  	protects  	 VBZ	O
cardiomyocytes  	cardiomyocytes  	 VBN	O
from  	from  	 IN	O
advanced  	advanced  	 JJ	O
oxidation  	oxidation  	 JJ	B-NP
protein  	protein  	 NN	I-NP
product‑induced  	product‑induced  	 CD	I-NP
apoptosis  	apoptosis  	 NN	O
via  	via  	 IN	O
the  	the  	 DT	O
PI3K 	PI3K 	 FW	O
/ 	/ 	 FW	O
Akt 	Akt 	 FW	B-NP
/ 	/ 	 FW	I-NP
Bad  	Bad  	 FW	I-NP
signaling  	signaling  	 FW	I-NP
pathway  	pathway  	 FW	I-NP
Cardiomyocyte  	Cardiomyocyte  	 FW	I-NP
apoptosis  	apoptosis  	 FW	I-NP
is  	is  	 VBZ	O
a  	a  	 DT	O
major  	major  	 JJ	O
event  	event  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
pathogenesis  	pathogenesis  	 NN	B-NP
of  	of  	 IN	I-NP
diabetic  	diabetic  	 JJ	I-NP
cardiomyopathy 	cardiomyopathy 	 NN	I-NP
.  	.  	 .	O
Currently 	Currently 	 RB	O
,  	,  	 ,	O
no  	no  	 DT	O
single  	single  	 JJ	O
effective  	effective  	 JJ	O
treatment  	treatment  	 NN	O
for  	for  	 IN	O
diabetic  	diabetic  	 JJ	B-NP
cardiomyopathy  	cardiomyopathy  	 NN	I-NP
exists 	exists 	 VBZ	O
.  	.  	 .	O
The  	The  	 DT	O
present  	present  	 JJ	O
study  	study  	 NN	O
investigated  	investigated  	 VBN	O
whether  	whether  	 IN	O
advanced  	advanced  	 JJ	B-NP
oxidative  	oxidative  	 JJ	I-NP
protein  	protein  	 NN	I-NP
products  	products  	 NNS	I-NP
( 	( 	 -LRB-	O
AOPPs 	AOPPs 	 NNP	B-NP
)  	)  	 -RRB-	O
have  	have  	 VBP	O
a  	a  	 DT	O
detrimental  	detrimental  	 JJ	B-NP
role  	role  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
survival  	survival  	 NN	O
of  	of  	 IN	O
cardiomyocytes  	cardiomyocytes  	 NN	B-NP
and  	and  	 CC	O
if  	if  	 IN	O
glucagon‑like  	glucagon‑like  	 NNP	B-NP
peptide‑1  	peptide‑1  	 NNP	O
( 	( 	 -LRB-	O
GLP‑1 	GLP‑1 	 NNP	B-NP
)  	)  	 -RRB-	O
exerts  	exerts  	 VBZ	O
a  	a  	 DT	O
cardioprotective  	cardioprotective  	 JJ	B-NP
effect  	effect  	 NN	I-NP
under  	under  	 IN	O
these  	these  	 DT	O
circumstances 	circumstances 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
present  	present  	 JJ	O
study  	study  	 NN	O
also  	also  	 RB	O
aimed  	aimed  	 VBN	O
to  	to  	 TO	O
determine  	determine  	 VB	O
the  	the  	 DT	O
underlying  	underlying  	 JJ	O
mechanisms 	mechanisms 	 NNS	O
.  	.  	 .	O
H9c2 cells  	H9c2 cells  	 NNP	O
were  	were  	 VBD	O
exposed  	exposed  	 VBN	O
to  	to  	 TO	O
increasing  	increasing  	 VBG	B-NP
concentrations  	concentrations  	 NNS	I-NP
of  	of  	 IN	O
AOPPs  	AOPPs  	 JJ	O
in  	in  	 IN	O
the  	the  	 DT	O
presence  	presence  	 NN	O
or  	or  	 CC	O
absence  	absence  	 NN	B-NP
of  	of  	 IN	I-NP
GLP‑1 	GLP‑1 	 NNP	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
viability  	viability  	 NN	O
and  	and  	 CC	O
apoptotic  	apoptotic  	 JJ	B-NP
rate  	rate  	 NN	I-NP
were  	were  	 VBD	O
detected  	detected  	 VBN	O
using  	using  	 VBG	O
a  	a  	 DT	O
cell  	cell  	 NN	O
counting  	counting  	 VBG	B-NP
kit‑8 assay  	kit‑8 assay  	 NNP	I-NP
and  	and  	 CC	O
flow  	flow  	 NN	B-NP
cytometry 	cytometry 	 NN	I-NP
,  	,  	 ,	O
respectively 	respectively 	 RB	O
.  	.  	 .	O
In  	In  	 IN	O
addition 	addition 	 NN	B-NP
,  	,  	 ,	O
a  	a  	 DT	O
phosphatidylinositol‑4,5‑bisphosphate 3‑kinase  	phosphatidylinositol‑4,5‑bisphosphate 3‑kinase  	 NNP	B-NP
( 	( 	 -LRB-	O
PI3K 	PI3K 	 NNP	O
)  	)  	 -RRB-	O
inhibitor 	inhibitor 	 NN	O
,  	,  	 ,	O
LY294002 	LY294002 	 NNP	O
,  	,  	 ,	O
was  	was  	 VBD	O
employed  	employed  	 VBN	O
to  	to  	 TO	O
illustrate  	illustrate  	 VB	O
the  	the  	 DT	O
mechanism  	mechanism  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
antiapoptotic  	antiapoptotic  	 JJ	B-NP
effect  	effect  	 NN	I-NP
of  	of  	 IN	I-NP
GLP‑1 	GLP‑1 	 CD	I-NP
.  	.  	 .	O
The  	The  	 DT	O
expression  	expression  	 NN	B-NP
levels  	levels  	 NNS	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
apoptotic‑associated  	apoptotic‑associated  	 CD	I-NP
proteins 	proteins 	 NNS	O
,  	,  	 ,	O
Akt 	Akt 	 NNP	B-NP
,  	,  	 ,	O
B‑cell  	B‑cell  	 CD	B-NP
lymphoma  	lymphoma  	 NNS	I-NP
( 	( 	 -LRB-	O
Bcl 	Bcl 	 NNP	B-NP
) 	) 	 -RRB-	O
‑2 	‑2 	 NNP	O
,  	,  	 ,	O
Bcl‑2‑associated  	Bcl‑2‑associated  	 CD	B-NP
death  	death  	 NN	I-NP
promoter  	promoter  	 NN	O
( 	( 	 -LRB-	O
Bad 	Bad 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
Bcl‑2‑associated X protein  	Bcl‑2‑associated X protein  	 NNP	B-NP
( 	( 	 -LRB-	O
Bax 	Bax 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
caspase‑3 were  	caspase‑3 were  	 RB	O
measured  	measured  	 VBN	O
by  	by  	 IN	O
western  	western  	 JJ	O
blotting 	blotting 	 NN	O
.  	.  	 .	O
It  	It  	 PRP	O
was  	was  	 VBD	O
revealed  	revealed  	 VBN	O
that  	that  	 IN	O
GLP‑1 significantly  	GLP‑1 significantly  	 CD	B-NP
attenuated  	attenuated  	 CD	O
AOPP‑induced  	AOPP‑induced  	 CD	O
cell  	cell  	 NN	O
toxicity  	toxicity  	 NN	O
and  	and  	 CC	O
apoptosis 	apoptosis 	 NN	B-NP
.  	.  	 .	O
AOPPs  	AOPPs  	 NNP	B-NP
inactivated  	inactivated  	 VBD	O
the  	the  	 DT	O
phosphorylation  	phosphorylation  	 NN	B-NP
of  	of  	 IN	I-NP
Akt 	Akt 	 NNP	I-NP
,  	,  	 ,	O
reduced  	reduced  	 VBD	O
the  	the  	 DT	O
phosphorylation  	phosphorylation  	 NN	B-NP
of  	of  	 IN	O
Bad 	Bad 	 NNP	O
,  	,  	 ,	O
decreased  	decreased  	 VBD	O
the  	the  	 DT	O
expression  	expression  	 NN	O
of  	of  	 IN	O
Bcl‑2 	Bcl‑2 	 NNP	B-NP
,  	,  	 ,	O
increased  	increased  	 VBD	O
the  	the  	 DT	O
expression  	expression  	 NN	O
of  	of  	 IN	O
Bax  	Bax  	 NNP	O
and  	and  	 CC	O
the  	the  	 DT	O
activation  	activation  	 NN	B-NP
of  	of  	 IN	I-NP
caspase‑3 in  	caspase‑3 in  	 CD	I-NP
H9c2 cells 	H9c2 cells 	 CD	O
.  	.  	 .	O
GLP‑1 reversed  	GLP‑1 reversed  	 CD	B-NP
the  	the  	 DT	O
above  	above  	 JJ	O
changes  	changes  	 NNS	O
induced  	induced  	 VBN	O
by  	by  	 IN	O
AOPPs  	AOPPs  	 JJ	O
and  	and  	 CC	O
the  	the  	 DT	O
protective  	protective  	 JJ	B-NP
effects  	effects  	 NNS	I-NP
of  	of  	 IN	I-NP
GLP‑1 were  	GLP‑1 were  	 NNP	I-NP
abolished  	abolished  	 VBD	O
by  	by  	 IN	O
the  	the  	 DT	O
PI3K  	PI3K  	 JJ	O
inhibitor 	inhibitor 	 NN	O
,  	,  	 ,	O
LY294002 	LY294002 	 NNP	O
.  	.  	 .	O
In  	In  	 IN	O
conclusion 	conclusion 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
present  	present  	 JJ	O
data  	data  	 NNS	O
suggested  	suggested  	 VBD	O
that  	that  	 IN	O
GLP‑1 protected  	GLP‑1 protected  	 CD	B-NP
cardiomyocytes  	cardiomyocytes  	 NN	O
against  	against  	 IN	O
AOPP‑induced  	AOPP‑induced  	 CD	B-NP
apoptosis 	apoptosis 	 NN	O
,  	,  	 ,	O
predominantly  	predominantly  	 RB	O
via  	via  	 IN	O
the  	the  	 DT	O
PI3K 	PI3K 	 NNP	O
/ 	/ 	 NNP	O
Akt 	Akt 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
Bad  	Bad  	 NNP	I-NP
pathway 	pathway 	 NN	I-NP
.  	.  	 .	O
These  	These  	 DT	O
results  	results  	 NNS	O
provided  	provided  	 VBD	O
a  	a  	 DT	O
conceivable  	conceivable  	 JJ	O
mechanism  	mechanism  	 NN	O
for  	for  	 IN	O
the  	the  	 DT	O
development  	development  	 NN	O
of  	of  	 IN	O
diabetic  	diabetic  	 JJ	B-NP
cardiomyopathy  	cardiomyopathy  	 NN	I-NP
and  	and  	 CC	O
rendered  	rendered  	 VBD	O
a  	a  	 DT	O
novel  	novel  	 NN	O
application  	application  	 NN	O
of  	of  	 IN	O
GLP‑1 exerting  	GLP‑1 exerting  	 CD	B-NP
favorable  	favorable  	 JJ	O
cardiac  	cardiac  	 JJ	B-NP
effects  	effects  	 NNS	I-NP
for  	for  	 IN	O
the  	the  	 DT	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
diabetic  	diabetic  	 JJ	B-NP
cardiomyopathy 	cardiomyopathy 	 NN	I-NP
.  	.  	 .	O
